Back
NVIDIA Vs. Nektar Therapeutics Sector Stock Comparison
Buy
70
NVDA
NVIDIA
Last Price:
$180.80
Seasonality Move:
15.78%
Buy
51
NKTR
Nektar Therapeutics
Last Price:
$21.61
Seasonality Move:
-1.52%
Buy
51
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $22.45. The Score for NKTR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $22.45Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.
NVDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 48.65 | Buy |
Relative Strength Index (14 RSI): | 66.49 | Buy |
Chaikin Money Flow: | 101108820 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (163.27 - 177.17) | Buy |
Bollinger Bands (100): | (111.19 - 160.95) | Buy |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.17 | Buy |
Relative Strength Index (14 RSI): | 50.31 | Buy |
Chaikin Money Flow: | -112923 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.78 - 25.16) | Sell |
Bollinger Bands (100): | (7.96 - 21.44) | Buy |
NVDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 177.6 | Buy |
20-day SMA: | 172.89 | Buy |
50-day SMA: | 157.35 | Buy |
200-day SMA: | 135.58 | Buy |
8-day EMA: | 147.48 | Buy |
20-day EMA: | 89.61 | Buy |
50-day EMA: | 43.42 | Buy |
200-day EMA: | 12.02 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.69 | Sell |
20-day SMA: | 23.97 | Sell |
50-day SMA: | 18.95 | Buy |
200-day SMA: | 14.98 | Buy |
8-day EMA: | 18.7 | Buy |
20-day EMA: | 11.37 | Buy |
50-day EMA: | 5.51 | Buy |
200-day EMA: | 1.53 | Buy |
NVIDIA Earnings Growth & NVDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.24 per share, an increase this year of $1.72 per share, and an increase next year of $1.35 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.
NVIDIA Technical Analysis
Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |